Pyrvinium pamoate, an anthelmintic drug and inhibitor of the Wnt/β-catenin pathway, prevented the proliferation of breast cancer cells, especially CD44+CD24−/low and ALDH+ CSCs, via downregulating NANOG, OCT4, and SOX2 [46]. This evidence concerns the gene POU5F1 and breast carcinoma.